Summary: Rasagiline is a novel, investigational propargylamine that irreversibly and selectively inhibits monoamine oxidase type ... and irreversible inhibitor of MAO-B that has demonstrated ...

a MAO-B = monoamine oxidase type B, MAO-A = monoamine oxidase type A. b Expressed as the molar concentration of drug required to inhibit enzyme activity by 50% (nmol/L). c Expressed as the ...

Tobacco and coffee contain bioactive compounds that may reduce Parkinson's disease risk by targeting key pathways such as MAO ...

Memantine as well as cholinesterase inhibitors are named in the long online version. 1. Gray R, Ives N, Rick C, et al.: Long-term effectiveness of dopamine agonists and monoamine oxidase B ...

announced that KDS2010 is a new reversible selective monoamine oxidase B inhibitor being studied for its potential in treating neurodegenerative diseases like Alzheimer’s disease. KDS2010 ...